Ivabradine in Chronic Heart Failure
Heart failure (HF) is an epidemic of cardiovascular disease resulting in impaired function and worsened quality of life (QOL) of HF patients. Increased heart rate correlates with poor outcomes in these patients; therefore, its reduction may be beneficial in reducing hospitalization for worsening HF....
Main Authors: | Hadeer Eid, Ebtissam Darweesh, Nagwa Ali Sabri, Naglaa Bazan |
---|---|
Format: | Article |
Language: | English |
Published: |
Ain Shams University
2020-06-01
|
Series: | Archives of Pharmaceutical Sciences Ain Shams University |
Subjects: | |
Online Access: | https://aps.journals.ekb.eg/article_102067.html |
Similar Items
-
Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
by: Hadeer Eid, et al.
Published: (2020-12-01) -
IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01) -
ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01) -
Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
by: Korhan Soylu, et al.
Published: (2020-08-01) -
Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)